FDA approves first drug for hallucinations and delusions associated with PD
On April 29, the U.S. the Food and Drug Administration (FDA) approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions…
Web Exclusives
Telephone CPR improves cardiac arrest outcomes
A Telephone Cardiopulmonary Resuscitation (TCPR) program increased survival rates and favorable outcomes for patients who experienced an out-of-hospital cardiac arrest, according to a study…
Early results from immunotherapy in patients with advanced leukemia positive
A small, early study in the Journal of Clinical Investigation reports that 93% of patients with advanced leukemia were in remission after immunotherapy. Read…
FDA proposes ban on ESDs for treating self-injurious behavior
On April 22, the U.S. the Food and Drug Administration (FDA) proposed a ban on electrical stimulation devices (ESDs) used for self-injurious or aggressive…
FDA approves new drug for chronic lymphocytic leukemia
On April 11, the U.S. the Food and Drug Administration (FDA) approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia who…
Tacrolimus effective in treating ocular graft-versus-host-disease
Compared to methylprednisolone, topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and is associated with fewer hypertensive side effects in…
Incident of ear infections in first year of life has decreased
A study in Pediatrics reports that the rates of ear infections during an infant’s first year have declined; the investigators suggest that higher rates…
Blood test can detect concussion one week after injury
Glial fibrillary acidic protein (GFAP), a biomarker that can indicate concussion, can be detected in the blood up to a week after head injury,…
FDA proposed ban on powdered medical gloves
The Food and Drug Administration (FDA) has proposed a ban on most powdered medical gloves in the U.S. Read more
FDA expands use of Xalkori
On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC) whose tumors…
Adding an I to SBAR: A new twist on communicating patient emergencies
In the 2000 report To Err is Human: Building a Safer Health System, the Institute of Medicine challenged the healthcare system to focus on…
FDA approves new treatment for patients with hemophilia B
On March 4, the Food and Drug Administration (FDA) approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults…
FDA approves first drug for hallucinations and delusions associated with PD
On April 29, the U.S. the Food and Drug Administration (FDA) approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations…
Telephone CPR improves cardiac arrest outcomes
A Telephone Cardiopulmonary Resuscitation (TCPR) program increased survival rates and favorable outcomes for patients who experienced an out-of-hospital cardiac arrest, according to…
Early results from immunotherapy in patients with advanced leukemia positive
A small, early study in the Journal of Clinical Investigation reports that 93% of patients with advanced leukemia were in remission after…
FDA proposes ban on ESDs for treating self-injurious behavior
On April 22, the U.S. the Food and Drug Administration (FDA) proposed a ban on electrical stimulation devices (ESDs) used for self-injurious…
FDA approves new drug for chronic lymphocytic leukemia
On April 11, the U.S. the Food and Drug Administration (FDA) approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic…
Tacrolimus effective in treating ocular graft-versus-host-disease
Compared to methylprednisolone, topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and is associated with fewer hypertensive side…
Incident of ear infections in first year of life has decreased
A study in Pediatrics reports that the rates of ear infections during an infant’s first year have declined; the investigators suggest that…
Blood test can detect concussion one week after injury
Glial fibrillary acidic protein (GFAP), a biomarker that can indicate concussion, can be detected in the blood up to a week after…
FDA proposed ban on powdered medical gloves
The Food and Drug Administration (FDA) has proposed a ban on most powdered medical gloves in the U.S. Read more
FDA expands use of Xalkori
On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC)…
Adding an I to SBAR: A new twist on communicating patient emergencies
In the 2000 report To Err is Human: Building a Safer Health System, the Institute of Medicine challenged the healthcare system to…
FDA approves new treatment for patients with hemophilia B
On March 4, the Food and Drug Administration (FDA) approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.